Wave Life Sciences says GSK selects hepatology siRNA candidate, triggering $12 million milestone

GSK has selected a hepatology siRNA candidate to move into its development pipeline under its collaboration with Wave Life Sciences, using Wave’s GalNAc-siRNA design.